Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3
2024 · Cell Reports Medicine · 56 citations
https://doi.org/10.1016/j.xcrm.2023.101357
D
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
230
Citations
10
h-index
10
i10-index
Dianping Yu is an academic researcher from State Administration of Traditional Chinese Medicine of the People's Republic of China. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis & RNA modifications and cancer. The author has an h-index of 10, co-authored 12 publications.
Papers by this author
worksDemethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22
2024 · Acta Pharmaceutica Sinica B · 26 citations
https://doi.org/10.1016/j.apsb.2024.08.004
Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapy
2023 · Clinical and Translational Medicine · 23 citations
https://doi.org/10.1002/ctm2.1449
Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation
2024 · Advanced Science · 15 citations
https://doi.org/10.1002/advs.202413122
Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancer
2025 · Signal Transduction and Targeted Therapy · 12 citations
https://doi.org/10.1038/s41392-025-02296-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat